Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide

Tumor Treating Field (TTFields) therapy has demonstrated efficacy in a Phase 3 study of newly diagnosed glioblastoma (GB) following radiation (RT) and temozolomide (TMZ). We report the appearance of an isolated satellite anterior temporal lobe lesion, 2 months post primary RT/TMZ directed at the pri...

Full description

Bibliographic Details
Main Authors: H. Ian Robins, HuyTram N. Nguyen, Aaron Field, Steven Howard, Shahriar Salamat, Dustin A. Deming
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Oncology
Subjects:
glioblastoma
tumor treating fields
optune®
genomics
temozolomide
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00451/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2018.00451/full

Similar Items